Realm Therapeutics plc American Depositary Shares
RLM
RLM was delisted on the 30th of July, 2019.
3 hedge funds and large institutions have $4.23M invested in Realm Therapeutics plc American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$4.38M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$1.55M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.98K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $3.05M | +$4.38M | +1,021,484 | New |
|
|
BI
2
BVF Inc
San Francisco,
California
| $1.17M | +$1.55M | +360,866 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $6K | +$7.98K | +1,860 | New |
|
RLM Hedge Fund Activity: Q3 2018 in Review
3 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Realm Therapeutics plc American Depositary Shares (RLM) for Q3 2018, worth a combined $4.23M.
Buyers outnumbered sellers: 3 funds opened new RLM positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $4.38M.
- 3 institutional investors held Realm Therapeutics plc American Depositary Shares (RLM) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $4.23M of Realm Therapeutics plc American Depositary Shares stock for Q3 2018.
- 3 funds opened new Realm Therapeutics plc American Depositary Shares positions in Q3 2018 and 0 closed out, a net change of +3 holders.
- The largest Realm Therapeutics plc American Depositary Shares buyer in Q3 2018 was OrbiMed, an estimated $4.38M added.
Based on aggregated 13F filings for Q3 2018.